Morgan Stanley flags Amgen's edge after heart-drug rival stumbles
A private meeting with Amgen management left Morgan Stanley with a very different read than the broader market’s.
We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnectA private meeting with Amgen management left Morgan Stanley with a very different read than the broader market’s.
Jamie Dimon is warning Wall Street that Main Street may not be ready for what comes next.
Netflix bowed out of the bidding war. Was it the right move?
Shoppers are the reason, and the cuts now reach well past the soda aisle.
Nike stock slides as brand faces backlash and S&P 100 exit
Cryptocurrencies and companies associated with them were having quite a banner trading session.
Wall Street reacts as the drugmaker’s experimental medication hits a roadblock.
Investors were caught off-guard by the announcement of the CEO's resignation.
The agentic shopping revolution is already running into a major roadblock: tension over who controls the experience and the related data.
HF Sinclair (DINO) stock drops 6% after a 21% rally—key levels, RSI overbought signal, valuation, and catalysts like buybacks.
Today reads warmer than 22 of the last 28 scored days. Click a bar to read that day's stories.